nodes	percent_of_prediction	percent_of_DWPC	metapath
Olanzapine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.271	1	CbGbCtD
Olanzapine—HTR2A—phrenic nerve—amyotrophic lateral sclerosis	0.0305	0.0598	CbGeAlD
Olanzapine—HTR3A—cranial nerve—amyotrophic lateral sclerosis	0.0197	0.0386	CbGeAlD
Olanzapine—HTR1B—cranial nerve—amyotrophic lateral sclerosis	0.0165	0.0324	CbGeAlD
Olanzapine—HTR1D—cranial nerve—amyotrophic lateral sclerosis	0.016	0.0314	CbGeAlD
Olanzapine—HTR7—cranial nerve—amyotrophic lateral sclerosis	0.0127	0.025	CbGeAlD
Olanzapine—HTR7—pons—amyotrophic lateral sclerosis	0.0126	0.0247	CbGeAlD
Olanzapine—DRD1—nerve—amyotrophic lateral sclerosis	0.0105	0.0205	CbGeAlD
Olanzapine—HTR3A—nerve—amyotrophic lateral sclerosis	0.0101	0.0198	CbGeAlD
Olanzapine—HTR5A—nervous system—amyotrophic lateral sclerosis	0.00943	0.0185	CbGeAlD
Olanzapine—HTR5A—central nervous system—amyotrophic lateral sclerosis	0.00908	0.0178	CbGeAlD
Olanzapine—HTR7—peripheral nervous system—amyotrophic lateral sclerosis	0.00838	0.0164	CbGeAlD
Olanzapine—HTR2A—cranial nerve—amyotrophic lateral sclerosis	0.00795	0.0156	CbGeAlD
Olanzapine—HTR2A—pons—amyotrophic lateral sclerosis	0.00785	0.0154	CbGeAlD
Olanzapine—HTR1E—brainstem—amyotrophic lateral sclerosis	0.00769	0.0151	CbGeAlD
Olanzapine—HTR5A—brain—amyotrophic lateral sclerosis	0.00721	0.0141	CbGeAlD
Olanzapine—HTR2A—hindlimb—amyotrophic lateral sclerosis	0.0067	0.0131	CbGeAlD
Olanzapine—HTR7—nerve—amyotrophic lateral sclerosis	0.00653	0.0128	CbGeAlD
Olanzapine—DRD2—nerve—amyotrophic lateral sclerosis	0.00617	0.0121	CbGeAlD
Olanzapine—ADRA2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00614	0.012	CbGeAlD
Olanzapine—HTR2A—appendage—amyotrophic lateral sclerosis	0.00574	0.0113	CbGeAlD
Olanzapine—HTR2A—peripheral nervous system—amyotrophic lateral sclerosis	0.00522	0.0102	CbGeAlD
Olanzapine—HTR1A—hindbrain—amyotrophic lateral sclerosis	0.00512	0.01	CbGeAlD
Olanzapine—H1F0—embryo—amyotrophic lateral sclerosis	0.00496	0.00972	CbGeAlD
Olanzapine—HTR7—hindbrain—amyotrophic lateral sclerosis	0.00489	0.00959	CbGeAlD
Olanzapine—ADRA1A—hindbrain—amyotrophic lateral sclerosis	0.00472	0.00925	CbGeAlD
Olanzapine—DRD2—hindbrain—amyotrophic lateral sclerosis	0.00462	0.00907	CbGeAlD
Olanzapine—DRD1—brainstem—amyotrophic lateral sclerosis	0.00449	0.0088	CbGeAlD
Olanzapine—HTR3A—brainstem—amyotrophic lateral sclerosis	0.00433	0.00849	CbGeAlD
Olanzapine—HTR2A—nerve—amyotrophic lateral sclerosis	0.00407	0.00798	CbGeAlD
Olanzapine—HTR1E—nervous system—amyotrophic lateral sclerosis	0.00403	0.00789	CbGeAlD
Olanzapine—HTR1E—central nervous system—amyotrophic lateral sclerosis	0.00388	0.0076	CbGeAlD
Olanzapine—HTR1B—brainstem—amyotrophic lateral sclerosis	0.00363	0.00713	CbGeAlD
Olanzapine—DRD4—brain—amyotrophic lateral sclerosis	0.00357	0.007	CbGeAlD
Olanzapine—CHRM4—nervous system—amyotrophic lateral sclerosis	0.00353	0.00692	CbGeAlD
Olanzapine—HTR1D—brainstem—amyotrophic lateral sclerosis	0.00352	0.0069	CbGeAlD
Olanzapine—HTR2C—brainstem—amyotrophic lateral sclerosis	0.00348	0.00683	CbGeAlD
Olanzapine—CHRM4—central nervous system—amyotrophic lateral sclerosis	0.0034	0.00666	CbGeAlD
Olanzapine—DRD3—nervous system—amyotrophic lateral sclerosis	0.00328	0.00644	CbGeAlD
Olanzapine—FMO3—nervous system—amyotrophic lateral sclerosis	0.00325	0.00636	CbGeAlD
Olanzapine—H1F0—medulla oblongata—amyotrophic lateral sclerosis	0.00317	0.00621	CbGeAlD
Olanzapine—DRD3—central nervous system—amyotrophic lateral sclerosis	0.00316	0.0062	CbGeAlD
Olanzapine—HTR6—nervous system—amyotrophic lateral sclerosis	0.00316	0.00619	CbGeAlD
Olanzapine—FMO3—central nervous system—amyotrophic lateral sclerosis	0.00312	0.00613	CbGeAlD
Olanzapine—HTR1E—brain—amyotrophic lateral sclerosis	0.00308	0.00603	CbGeAlD
Olanzapine—DRD5—nervous system—amyotrophic lateral sclerosis	0.00308	0.00603	CbGeAlD
Olanzapine—HTR2A—hindbrain—amyotrophic lateral sclerosis	0.00305	0.00598	CbGeAlD
Olanzapine—HTR6—central nervous system—amyotrophic lateral sclerosis	0.00304	0.00596	CbGeAlD
Olanzapine—DRD5—central nervous system—amyotrophic lateral sclerosis	0.00296	0.00581	CbGeAlD
Olanzapine—HTR1A—brainstem—amyotrophic lateral sclerosis	0.00293	0.00575	CbGeAlD
Olanzapine—HRH2—nervous system—amyotrophic lateral sclerosis	0.00289	0.00566	CbGeAlD
Olanzapine—H1F0—spinal cord—amyotrophic lateral sclerosis	0.00282	0.00554	CbGeAlD
Olanzapine—HTR7—brainstem—amyotrophic lateral sclerosis	0.0028	0.0055	CbGeAlD
Olanzapine—HRH2—central nervous system—amyotrophic lateral sclerosis	0.00278	0.00545	CbGeAlD
Olanzapine—CYP2D6—hindbrain—amyotrophic lateral sclerosis	0.00278	0.00545	CbGeAlD
Olanzapine—CHRM5—nervous system—amyotrophic lateral sclerosis	0.00276	0.00541	CbGeAlD
Olanzapine—ADRA1A—brainstem—amyotrophic lateral sclerosis	0.0027	0.0053	CbGeAlD
Olanzapine—CHRM4—brain—amyotrophic lateral sclerosis	0.0027	0.00529	CbGeAlD
Olanzapine—CHRM5—central nervous system—amyotrophic lateral sclerosis	0.00266	0.00521	CbGeAlD
Olanzapine—DRD2—brainstem—amyotrophic lateral sclerosis	0.00265	0.0052	CbGeAlD
Olanzapine—ADRA1B—nervous system—amyotrophic lateral sclerosis	0.00252	0.00494	CbGeAlD
Olanzapine—DRD3—brain—amyotrophic lateral sclerosis	0.00251	0.00492	CbGeAlD
Olanzapine—FMO3—brain—amyotrophic lateral sclerosis	0.00248	0.00486	CbGeAlD
Olanzapine—HTR2C—medulla oblongata—amyotrophic lateral sclerosis	0.00243	0.00476	CbGeAlD
Olanzapine—ADRA1B—central nervous system—amyotrophic lateral sclerosis	0.00243	0.00476	CbGeAlD
Olanzapine—HTR6—brain—amyotrophic lateral sclerosis	0.00242	0.00474	CbGeAlD
Olanzapine—ORM1—spinal cord—amyotrophic lateral sclerosis	0.00241	0.00473	CbGeAlD
Olanzapine—H1F0—nervous system—amyotrophic lateral sclerosis	0.00238	0.00467	CbGeAlD
Olanzapine—DRD5—brain—amyotrophic lateral sclerosis	0.00235	0.00461	CbGeAlD
Olanzapine—DRD1—nervous system—amyotrophic lateral sclerosis	0.00235	0.00461	CbGeAlD
Olanzapine—H1F0—central nervous system—amyotrophic lateral sclerosis	0.00229	0.00449	CbGeAlD
Olanzapine—HTR3A—nervous system—amyotrophic lateral sclerosis	0.00227	0.00445	CbGeAlD
Olanzapine—DRD1—central nervous system—amyotrophic lateral sclerosis	0.00226	0.00444	CbGeAlD
Olanzapine—HTR1B—spinal cord—amyotrophic lateral sclerosis	0.00226	0.00443	CbGeAlD
Olanzapine—H1F0—cerebellum—amyotrophic lateral sclerosis	0.00224	0.00439	CbGeAlD
Olanzapine—HRH2—brain—amyotrophic lateral sclerosis	0.00221	0.00433	CbGeAlD
Olanzapine—HTR3A—central nervous system—amyotrophic lateral sclerosis	0.00219	0.00428	CbGeAlD
Olanzapine—HTR2C—spinal cord—amyotrophic lateral sclerosis	0.00217	0.00425	CbGeAlD
Olanzapine—CHRM5—brain—amyotrophic lateral sclerosis	0.00211	0.00414	CbGeAlD
Olanzapine—ORM1—nervous system—amyotrophic lateral sclerosis	0.00203	0.00398	CbGeAlD
Olanzapine—ORM1—central nervous system—amyotrophic lateral sclerosis	0.00196	0.00383	CbGeAlD
Olanzapine—HTR7—medulla oblongata—amyotrophic lateral sclerosis	0.00195	0.00383	CbGeAlD
Olanzapine—ADRA1B—brain—amyotrophic lateral sclerosis	0.00193	0.00378	CbGeAlD
Olanzapine—HTR2A—embryo—amyotrophic lateral sclerosis	0.00191	0.00374	CbGeAlD
Olanzapine—HTR1B—nervous system—amyotrophic lateral sclerosis	0.0019	0.00373	CbGeAlD
Olanzapine—CHRM2—nervous system—amyotrophic lateral sclerosis	0.00189	0.00371	CbGeAlD
Olanzapine—HTR1D—nervous system—amyotrophic lateral sclerosis	0.00184	0.00362	CbGeAlD
Olanzapine—HTR1B—central nervous system—amyotrophic lateral sclerosis	0.00183	0.00359	CbGeAlD
Olanzapine—HTR2C—nervous system—amyotrophic lateral sclerosis	0.00183	0.00358	CbGeAlD
Olanzapine—HTR1A—spinal cord—amyotrophic lateral sclerosis	0.00182	0.00358	CbGeAlD
Olanzapine—CHRM2—central nervous system—amyotrophic lateral sclerosis	0.00182	0.00358	CbGeAlD
Olanzapine—H1F0—brain—amyotrophic lateral sclerosis	0.00182	0.00357	CbGeAlD
Olanzapine—ADRA2C—medulla oblongata—amyotrophic lateral sclerosis	0.0018	0.00352	CbGeAlD
Olanzapine—DRD1—brain—amyotrophic lateral sclerosis	0.0018	0.00352	CbGeAlD
Olanzapine—HTR1D—central nervous system—amyotrophic lateral sclerosis	0.00178	0.00348	CbGeAlD
Olanzapine—HTR2C—central nervous system—amyotrophic lateral sclerosis	0.00176	0.00345	CbGeAlD
Olanzapine—HTR2A—brainstem—amyotrophic lateral sclerosis	0.00175	0.00343	CbGeAlD
Olanzapine—HTR7—spinal cord—amyotrophic lateral sclerosis	0.00174	0.00342	CbGeAlD
Olanzapine—HTR3A—brain—amyotrophic lateral sclerosis	0.00174	0.0034	CbGeAlD
Olanzapine—CHRM1—nervous system—amyotrophic lateral sclerosis	0.00172	0.00338	CbGeAlD
Olanzapine—HTR2B—nervous system—amyotrophic lateral sclerosis	0.00172	0.00336	CbGeAlD
Olanzapine—CHRM1—central nervous system—amyotrophic lateral sclerosis	0.00166	0.00325	CbGeAlD
Olanzapine—HTR2B—central nervous system—amyotrophic lateral sclerosis	0.00165	0.00324	CbGeAlD
Olanzapine—ADRA2C—spinal cord—amyotrophic lateral sclerosis	0.0016	0.00314	CbGeAlD
Olanzapine—CYP2D6—brainstem—amyotrophic lateral sclerosis	0.00159	0.00312	CbGeAlD
Olanzapine—CHRM3—nervous system—amyotrophic lateral sclerosis	0.00154	0.00303	CbGeAlD
Olanzapine—HTR1A—nervous system—amyotrophic lateral sclerosis	0.00154	0.00301	CbGeAlD
Olanzapine—CHRM3—central nervous system—amyotrophic lateral sclerosis	0.00149	0.00291	CbGeAlD
Olanzapine—HTR1A—central nervous system—amyotrophic lateral sclerosis	0.00148	0.0029	CbGeAlD
Olanzapine—HTR7—nervous system—amyotrophic lateral sclerosis	0.00147	0.00288	CbGeAlD
Olanzapine—HTR1B—brain—amyotrophic lateral sclerosis	0.00146	0.00285	CbGeAlD
Olanzapine—CHRM2—brain—amyotrophic lateral sclerosis	0.00145	0.00284	CbGeAlD
Olanzapine—HTR1A—cerebellum—amyotrophic lateral sclerosis	0.00145	0.00284	CbGeAlD
Olanzapine—ADRA2A—medulla oblongata—amyotrophic lateral sclerosis	0.00143	0.00281	CbGeAlD
Olanzapine—ADRA1A—nervous system—amyotrophic lateral sclerosis	0.00142	0.00278	CbGeAlD
Olanzapine—HTR7—central nervous system—amyotrophic lateral sclerosis	0.00141	0.00277	CbGeAlD
Olanzapine—HTR1D—brain—amyotrophic lateral sclerosis	0.00141	0.00276	CbGeAlD
Olanzapine—HTR2C—brain—amyotrophic lateral sclerosis	0.0014	0.00274	CbGeAlD
Olanzapine—DRD2—nervous system—amyotrophic lateral sclerosis	0.00139	0.00272	CbGeAlD
Olanzapine—HTR7—cerebellum—amyotrophic lateral sclerosis	0.00138	0.00271	CbGeAlD
Olanzapine—ADRA1A—central nervous system—amyotrophic lateral sclerosis	0.00136	0.00267	CbGeAlD
Olanzapine—ALB—brain—amyotrophic lateral sclerosis	0.00136	0.00267	CbGeAlD
Olanzapine—ADRA2C—nervous system—amyotrophic lateral sclerosis	0.00135	0.00265	CbGeAlD
Olanzapine—DRD2—central nervous system—amyotrophic lateral sclerosis	0.00134	0.00262	CbGeAlD
Olanzapine—ADRA1A—cerebellum—amyotrophic lateral sclerosis	0.00133	0.00261	CbGeAlD
Olanzapine—CHRM1—brain—amyotrophic lateral sclerosis	0.00132	0.00258	CbGeAlD
Olanzapine—HTR2B—brain—amyotrophic lateral sclerosis	0.00131	0.00257	CbGeAlD
Olanzapine—DRD2—cerebellum—amyotrophic lateral sclerosis	0.00131	0.00256	CbGeAlD
Olanzapine—ADRA2C—central nervous system—amyotrophic lateral sclerosis	0.0013	0.00255	CbGeAlD
Olanzapine—ADRA2A—spinal cord—amyotrophic lateral sclerosis	0.00128	0.00251	CbGeAlD
Olanzapine—ADRA2C—cerebellum—amyotrophic lateral sclerosis	0.00127	0.00249	CbGeAlD
Olanzapine—ABCB1—embryo—amyotrophic lateral sclerosis	0.00125	0.00245	CbGeAlD
Olanzapine—HTR2A—medulla oblongata—amyotrophic lateral sclerosis	0.00122	0.00239	CbGeAlD
Olanzapine—CHRM3—brain—amyotrophic lateral sclerosis	0.00118	0.00231	CbGeAlD
Olanzapine—HTR1A—brain—amyotrophic lateral sclerosis	0.00117	0.0023	CbGeAlD
Olanzapine—HTR7—brain—amyotrophic lateral sclerosis	0.00112	0.0022	CbGeAlD
Olanzapine—HRH1—nervous system—amyotrophic lateral sclerosis	0.0011	0.00215	CbGeAlD
Olanzapine—HTR2A—spinal cord—amyotrophic lateral sclerosis	0.00109	0.00213	CbGeAlD
Olanzapine—ADRA1A—brain—amyotrophic lateral sclerosis	0.00108	0.00212	CbGeAlD
Olanzapine—ADRA2A—nervous system—amyotrophic lateral sclerosis	0.00108	0.00211	CbGeAlD
Olanzapine—DRD2—brain—amyotrophic lateral sclerosis	0.00106	0.00208	CbGeAlD
Olanzapine—HRH1—central nervous system—amyotrophic lateral sclerosis	0.00106	0.00207	CbGeAlD
Olanzapine—ADRA2A—central nervous system—amyotrophic lateral sclerosis	0.00104	0.00203	CbGeAlD
Olanzapine—ADRA2C—brain—amyotrophic lateral sclerosis	0.00103	0.00202	CbGeAlD
Olanzapine—ADRA2A—cerebellum—amyotrophic lateral sclerosis	0.00101	0.00199	CbGeAlD
Olanzapine—HTR2A—nervous system—amyotrophic lateral sclerosis	0.000916	0.0018	CbGeAlD
Olanzapine—HTR2A—central nervous system—amyotrophic lateral sclerosis	0.000882	0.00173	CbGeAlD
Olanzapine—HTR2A—cerebellum—amyotrophic lateral sclerosis	0.000862	0.00169	CbGeAlD
Olanzapine—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000848	0.00166	CbGeAlD
Olanzapine—HRH1—brain—amyotrophic lateral sclerosis	0.000838	0.00164	CbGeAlD
Olanzapine—CYP2D6—nervous system—amyotrophic lateral sclerosis	0.000834	0.00164	CbGeAlD
Olanzapine—ADRA2A—brain—amyotrophic lateral sclerosis	0.000823	0.00161	CbGeAlD
Olanzapine—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000816	0.0016	CbGeAlD
Olanzapine—CYP2D6—central nervous system—amyotrophic lateral sclerosis	0.000803	0.00158	CbGeAlD
Olanzapine—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000799	0.00157	CbGeAlD
Olanzapine—CYP2D6—cerebellum—amyotrophic lateral sclerosis	0.000785	0.00154	CbGeAlD
Olanzapine—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000712	0.0014	CbGeAlD
Olanzapine—HTR2A—brain—amyotrophic lateral sclerosis	0.0007	0.00137	CbGeAlD
Olanzapine—CYP2D6—brain—amyotrophic lateral sclerosis	0.000638	0.00125	CbGeAlD
Olanzapine—ABCB1—nervous system—amyotrophic lateral sclerosis	0.0006	0.00118	CbGeAlD
Olanzapine—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000578	0.00113	CbGeAlD
Olanzapine—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000565	0.00111	CbGeAlD
Olanzapine—ABCB1—brain—amyotrophic lateral sclerosis	0.000459	0.000899	CbGeAlD
Olanzapine—HTR1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.72e-05	0.00017	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.72e-05	0.00017	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.7e-05	0.000169	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.69e-05	0.000169	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	3.69e-05	0.000169	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.68e-05	0.000168	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.67e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.67e-05	0.000168	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.66e-05	0.000168	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.65e-05	0.000167	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.63e-05	0.000166	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.62e-05	0.000166	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	3.62e-05	0.000166	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.62e-05	0.000165	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.57e-05	0.000163	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.57e-05	0.000163	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—VEGFA—amyotrophic lateral sclerosis	3.55e-05	0.000162	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.55e-05	0.000162	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.54e-05	0.000162	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	3.54e-05	0.000162	CbGpPWpGaD
Olanzapine—ADRA2B—Hemostasis—TP53—amyotrophic lateral sclerosis	3.54e-05	0.000162	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.53e-05	0.000162	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.53e-05	0.000161	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.5e-05	0.00016	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.5e-05	0.00016	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.49e-05	0.00016	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.48e-05	0.000159	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.46e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.45e-05	0.000158	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.43e-05	0.000157	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	3.4e-05	0.000156	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.37e-05	0.000154	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	3.37e-05	0.000154	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.34e-05	0.000153	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.31e-05	0.000151	CbGpPWpGaD
Olanzapine—ADRA2C—Hemostasis—TP53—amyotrophic lateral sclerosis	3.3e-05	0.000151	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.3e-05	0.000151	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.28e-05	0.00015	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—APOE—amyotrophic lateral sclerosis	3.28e-05	0.00015	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.26e-05	0.000149	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.24e-05	0.000148	CbGpPWpGaD
Olanzapine—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.24e-05	0.000148	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.22e-05	0.000147	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.18e-05	0.000145	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.17e-05	0.000145	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.17e-05	0.000145	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.16e-05	0.000145	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.16e-05	0.000145	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	3.16e-05	0.000144	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.16e-05	0.000144	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.15e-05	0.000144	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.14e-05	0.000144	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.14e-05	0.000144	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.11e-05	0.000142	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	3.1e-05	0.000142	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.08e-05	0.000141	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.05e-05	0.000139	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.03e-05	0.000139	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	3.03e-05	0.000139	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.03e-05	0.000139	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	3.03e-05	0.000139	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3e-05	0.000137	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.99e-05	0.000137	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.98e-05	0.000137	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.98e-05	0.000136	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.97e-05	0.000136	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.96e-05	0.000136	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.000135	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.95e-05	0.000135	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.94e-05	0.000134	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000134	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.92e-05	0.000133	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.91e-05	0.000133	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—APOE—amyotrophic lateral sclerosis	2.91e-05	0.000133	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.9e-05	0.000133	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.89e-05	0.000132	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	2.88e-05	0.000132	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.86e-05	0.000131	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.84e-05	0.00013	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.82e-05	0.000129	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.8e-05	0.000128	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.000128	CbGpPWpGaD
Olanzapine—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.78e-05	0.000127	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.75e-05	0.000126	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.73e-05	0.000125	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	2.71e-05	0.000124	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.7e-05	0.000124	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.7e-05	0.000123	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.69e-05	0.000123	CbGpPWpGaD
Olanzapine—ADRA2A—Hemostasis—TP53—amyotrophic lateral sclerosis	2.68e-05	0.000123	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.68e-05	0.000123	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.68e-05	0.000122	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—APOE—amyotrophic lateral sclerosis	2.67e-05	0.000122	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.65e-05	0.000121	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.63e-05	0.00012	CbGpPWpGaD
Olanzapine—HRH4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.63e-05	0.00012	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.63e-05	0.00012	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.62e-05	0.00012	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.61e-05	0.000119	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.59e-05	0.000118	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.58e-05	0.000118	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.56e-05	0.000117	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.5e-05	0.000114	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.49e-05	0.000114	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.45e-05	0.000112	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.45e-05	0.000112	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.44e-05	0.000112	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.44e-05	0.000112	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.44e-05	0.000112	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.44e-05	0.000111	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.43e-05	0.000111	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.43e-05	0.000111	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.42e-05	0.000111	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.41e-05	0.00011	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.4e-05	0.00011	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—C3—amyotrophic lateral sclerosis	2.4e-05	0.00011	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.37e-05	0.000108	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.34e-05	0.000107	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.33e-05	0.000107	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.33e-05	0.000107	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.3e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.3e-05	0.000105	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.3e-05	0.000105	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.3e-05	0.000105	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.3e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR1E—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.29e-05	0.000105	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.29e-05	0.000105	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.28e-05	0.000104	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.27e-05	0.000104	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.26e-05	0.000104	CbGpPWpGaD
Olanzapine—ADRA2C—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.25e-05	0.000103	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.24e-05	0.000103	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.24e-05	0.000102	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.23e-05	0.000102	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—APOE—amyotrophic lateral sclerosis	2.23e-05	0.000102	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.23e-05	0.000102	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.2e-05	0.000101	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.2e-05	0.000101	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.17e-05	9.94e-05	CbGpPWpGaD
Olanzapine—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	2.12e-05	9.69e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.11e-05	9.66e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	2.1e-05	9.63e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.1e-05	9.62e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.1e-05	9.6e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.09e-05	9.58e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.08e-05	9.52e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.07e-05	9.47e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.07e-05	9.46e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.07e-05	9.45e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.06e-05	9.42e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.05e-05	9.39e-05	CbGpPWpGaD
Olanzapine—HRH2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.04e-05	9.32e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.03e-05	9.27e-05	CbGpPWpGaD
Olanzapine—DRD5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.03e-05	9.26e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.02e-05	9.25e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-05	9.22e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	2.01e-05	9.2e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.01e-05	9.19e-05	CbGpPWpGaD
Olanzapine—CHRM3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.99e-05	9.11e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.99e-05	9.1e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.98e-05	9.07e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.98e-05	9.07e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.98e-05	9.05e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.96e-05	8.95e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.95e-05	8.93e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.95e-05	8.91e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	1.89e-05	8.64e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.89e-05	8.64e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.87e-05	8.55e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.87e-05	8.55e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	1.84e-05	8.44e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	1.84e-05	8.43e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.83e-05	8.36e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.8e-05	8.26e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.8e-05	8.21e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.79e-05	8.19e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.78e-05	8.15e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.77e-05	8.08e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.76e-05	8.04e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.75e-05	7.99e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	1.74e-05	7.95e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	1.72e-05	7.88e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.72e-05	7.86e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.71e-05	7.8e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.7e-05	7.76e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.65e-05	7.55e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.62e-05	7.43e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.59e-05	7.26e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.58e-05	7.25e-05	CbGpPWpGaD
Olanzapine—HTR6—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.56e-05	7.15e-05	CbGpPWpGaD
Olanzapine—HTR7—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.56e-05	7.14e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.56e-05	7.13e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.56e-05	7.12e-05	CbGpPWpGaD
Olanzapine—HTR1D—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.55e-05	7.1e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-05	7.09e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.55e-05	7.07e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.53e-05	7.01e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.53e-05	7e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.53e-05	6.98e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.52e-05	6.97e-05	CbGpPWpGaD
Olanzapine—HTR1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.52e-05	6.95e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.5e-05	6.87e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.5e-05	6.85e-05	CbGpPWpGaD
Olanzapine—DRD4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.49e-05	6.84e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.48e-05	6.78e-05	CbGpPWpGaD
Olanzapine—CHRM4—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.47e-05	6.75e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.47e-05	6.74e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	1.47e-05	6.74e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.47e-05	6.73e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.47e-05	6.7e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.46e-05	6.68e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.46e-05	6.67e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.45e-05	6.62e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.44e-05	6.6e-05	CbGpPWpGaD
Olanzapine—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.44e-05	6.6e-05	CbGpPWpGaD
Olanzapine—HTR2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.43e-05	6.53e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	1.42e-05	6.49e-05	CbGpPWpGaD
Olanzapine—CHRM5—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.41e-05	6.46e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	6.32e-05	CbGpPWpGaD
Olanzapine—DRD1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.35e-05	6.16e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.34e-05	6.15e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	1.34e-05	6.13e-05	CbGpPWpGaD
Olanzapine—DRD3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.33e-05	6.07e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	6.05e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	6.04e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.32e-05	6.02e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.31e-05	6e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.3e-05	5.94e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.3e-05	5.93e-05	CbGpPWpGaD
Olanzapine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.29e-05	5.92e-05	CbGpPWpGaD
Olanzapine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.26e-05	5.78e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.2e-05	5.51e-05	CbGpPWpGaD
Olanzapine—ADRA2B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.2e-05	5.48e-05	CbGpPWpGaD
Olanzapine—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.19e-05	5.45e-05	CbGpPWpGaD
Olanzapine—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.18e-05	5.4e-05	CbGpPWpGaD
Olanzapine—HTR1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.16e-05	5.29e-05	CbGpPWpGaD
Olanzapine—HTR2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.15e-05	5.27e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	1.14e-05	5.2e-05	CbGpPWpGaD
Olanzapine—ADRA2C—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.12e-05	5.12e-05	CbGpPWpGaD
Olanzapine—ADRA1B—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.1e-05	5.04e-05	CbGpPWpGaD
Olanzapine—DRD2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.02e-05	4.65e-05	CbGpPWpGaD
Olanzapine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	4.61e-05	CbGpPWpGaD
Olanzapine—HTR2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1e-05	4.57e-05	CbGpPWpGaD
Olanzapine—HRH1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.97e-06	4.56e-05	CbGpPWpGaD
Olanzapine—CHRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.94e-06	4.55e-05	CbGpPWpGaD
Olanzapine—CHRM3—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.91e-06	4.53e-05	CbGpPWpGaD
Olanzapine—CHRM2—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.81e-06	4.49e-05	CbGpPWpGaD
Olanzapine—ADRA1A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.79e-06	4.48e-05	CbGpPWpGaD
Olanzapine—ADRA2A—Signaling Pathways—TP53—amyotrophic lateral sclerosis	9.09e-06	4.16e-05	CbGpPWpGaD
Olanzapine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.78e-06	3.56e-05	CbGpPWpGaD
